Rossari Biotech Limited (ROSSARI) fundamentals
Rossari Biotech Limited is a listed company in Chemicals & Petrochemicals, part of the Chemicals sector, listed on the NSE as ROSSARI (ISIN INE02A801020). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Rossari Biotech Limited does
Rossari Biotech Limited is an India-based company. The Company is engaged in the manufacturing, selling and distribution of specialty chemicals. Its products cater to global brands in the Fast Moving Consumer Goods (FMCG) sector and find applications in a host of consumer centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. It operates through three segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals (TSC), and Animal Health and Nutrition (AHN). The HPPC produces acrylic polymers. The TSC provides solutions for pre-treatment, dyeing and printing, finishing, and specialty chemicals for the textile industry. The AHN provides wellness solutions for pet animals and poultry, focusing on their health and performance. Its products include DETPRO 2040 CP, Rossblue, Amido Silicones, Rosselectro C, NEOBIND 7050 SC LIQUID, and others. Its flagship brand is Freshee.
Valuation and market data
| Last close | ₹452.00 |
|---|---|
| Market capitalisation | ₹2,502 crore |
| Enterprise value | ₹2,593 crore |
| P/E (TTM) | 16.77 |
| Price to book | 1.88 |
| Price to sales (TTM) | 0.59 |
| Book value per share | ₹240.83 |
| Dividend yield | 11.06% |
| Sector | Chemicals |
| Industry | Chemicals & Petrochemicals |
| Listed since | Thu Jul 23 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹1,779 crore | ₹191 crore | ₹143 crore | 25.79 |
| Mar 2025 | ₹1,437 crore | ₹155 crore | ₹115 crore | 20.75 |
| Mar 2024 | ₹1,210 crore | ₹134 crore | ₹100 crore | 18.05 |
| Mar 2023 | ₹979 crore | ₹96 crore | ₹71 crore | 12.95 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 68.1% |
|---|---|
| Foreign institutions (FII) | 2.0% |
| Mutual funds | 9.8% |
| Other domestic institutions | 4.9% |
| Retail and others | 15.2% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.